Last reviewed · How we verify

NCT07202936

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Recruiting now Last updated 2 October 2025
What this trial tests

trial in Uterine Cervical Neoplasms in 250 participants. Currently enrolling.

Timeline
3 May 2024
Primary endpoint
1 May 2026
1 April 2027

Quick facts

Lead sponsorUniversity of Bern
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment250
Start date3 May 2024
Primary completion1 May 2026
Estimated completion1 April 2027
Sites1 location across Zimbabwe

Conditions studied

Sponsor

University of Bern

Who can join

Adults 18 to 65, female only, with Uterine Cervical Neoplasms or HIV I Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to improve cervical pre-cancer treatment outcomes among women living with HIV (WLWH), particularly in low and middle income countries (LMICs), by generating the evidence needed for post-treatment monitoring guidelines. The main questions it aims to answer are: * What is the risk of disease recurrence/persistence after cervical pre-cancer treatment among women living with HIV in Zimbabwe? * What is the predictive value of different human papillomavirus (HPV) and DNA methylation testing strategies for monitoring cervical disease recurrence/persistence after pre-cancer treatment? Participants will have cervical biopsies taken for histological assessment and cervical samples for HPV genotyping and DNA methylation testing. Researchers will follow all participating women every six months for 24 months to evaluate post-treatment monitoring and cervical disease outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Uterine Cervical Neoplasms

Currently open trials in the same condition.

Other University of Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07202936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing